Rising pollution levels, rapid urban construction and a persistent tendency to manage chronic conditions like asthma at home, ...
Arizona author and journalist Terry Green Sterling has non-tuberculous mycobacterial pulmonary disease — an ailment that's ...
Investor's Business Daily on MSN
This drug stock nears a buy point, with profit set to explode
This drug stock is testing a moving average in a base. This biopharma name has a patented technology to administer its drug.
Worldwide Medical Supply announces the release of its Finger Pulse Oximeter, which provides instant SpO2 and pulse rate ...
AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results